Markets:

Overview

News

Currencies

International

Treasuries

Lobe Sciences Ltd (CSE:LOBE)

0.0450 UNCHANGED

Streaming Delayed Price Updated: 2:06 PM EST, Feb 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lobe Sciences Ltd

< Previous 1 2 Next >

Lobe Sciences Initiates Phase 1 Clinical Trial of L-130

June 27, 2023

From Lobe Sciences Ltd.

Via Business Wire

Lobe Sciences Appoints Baxter Phillips III, MBA as Chief Operating Officer

June 07, 2023

From Lobe Sciences Ltd.

Via Business Wire

Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia™

May 17, 2023

From Lobe Sciences Ltd.

Via Business Wire

Chronic Cluster Headaches No More: The Promise Of Lobe Sciences' At-Home Psychedelic Treatments Without The Trip!

March 01, 2023

By Richard Dal Monte

Via TheNewswire.com

The Power Play by The Market Herald Releases New Interviews with ARway, Silver Bullet Mines, Galantas Gold, Lobe Sciences, Northstar Gold and Rover Metals Discussing Their Latest News

April 19, 2023

Via ACCESSWIRE

Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry

January 26, 2023

EQNX::TICKER_START (OTCQB:LOBEF),(NASDAQ:ATAI),(NASDAQ:CMPS),(NYSE:CYBN),(NASDAQ:MNMD) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Economy

Lobe Sciences, Ltd. Enters Collaborative Clinical Research Agreement with Integrative Headache Medicine of New York to Study the Effects of L-130 in the Treatment of Chronic Cluster Headache

January 26, 2023

Dr. Lauren R. Natbony to be Principal investigator Vancouver, BC – January 26, 2023 — Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) (“Lobe” or the “Company”), a North American Biopharmaceutical company...

Via FinancialNewsMedia

Lobe Sciences Ltd (LOBEF) increases its portfolio with several new chemical entities (NCEs)

January 19, 2023

Via AB Newswire

Topics Intellectual Property

Lobe Sciences Announces Incorporation of Australian Subsidiary

September 23, 2022

Vancouver, British Columbia--(Newsfile Corp. - September 23, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"),...

Via Newsfile

Lobe Sciences Announces Closing of Private Placement

September 08, 2022

Vancouver, British Columbia--(Newsfile Corp. - September 8, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"),...

Via Newsfile

Lobe Sciences and Cantheon Capital Enter into Exclusive Investment Agreement to Fund $1.5M USD Toward Clinical Trials in Australia

September 01, 2022

Vancouver, British Columbia--(Newsfile Corp. - September 1, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"),...

Via Newsfile

Topics Cannabis

Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) Featured in Coverage of Planet MicroCap’s Virtual Investor Conference

April 19, 2022

Via Investor Brand Network

Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event

March 07, 2022

Via Investor Brand Network

Lobe Sciences to Participate at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference

September 15, 2021

Vancouver, British Columbia--(Newsfile Corp. - September 15, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...

Via Newsfile

Lobe Sciences Provides Corporate Update to Investors and Stakeholders

September 13, 2021

Vancouver, British Columbia--(Newsfile Corp. - September 13, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...

Via Newsfile

Topics Cannabis Intellectual Property

Lobe Sciences to Present At H.C. Wainwright 23rd Annual Global Investment Conference

September 10, 2021

Vancouver, British Columbia--(Newsfile Corp. - September 10, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...

Via Newsfile

Lobe Sciences Appoints Albert "Skip" Rizzo, Ph.D to Scientific Advisory Board

August 23, 2021

Director, Medical Virtual Reality - Institute for Creative Technologies Research Professor - Dept. of Psychiatry and School of Gerontology University...

Via Newsfile

Lobe Sciences Appoints Gilberto Jesús Mendoza, President of the World Boxing Association, to Advisory Board

July 13, 2021

Vancouver, British Columbia--(Newsfile Corp. - July 13, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...

Via Newsfile

Lobe Sciences Clarifies Recent Promotional Activities at Request of OTC Markets

July 02, 2021

Vancouver, British Columbia--(Newsfile Corp. - July 2, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...

Via Newsfile

Lobe Sciences Appoints Charles Grob, MD to Scientific Advisory Board

June 28, 2021

Investigator, The Lundquist InstituteProfessor of Psychiatry & Biobehavioral Sciences and Pediatrics, David Geffen School of Medicine at UCLA Vancouver, British...

Via Newsfile

Lobe Sciences to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference

June 15, 2021

Vancouver, British Columbia--(Newsfile Corp. - June 15, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...

Via Newsfile

Lobe Sciences to Present at the LD Micro Invitational XI

June 07, 2021

Vancouver, British Columbia--(Newsfile Corp. - June 7, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...

Via Newsfile

Lobe Sciences Secures Production and Supply Agreement for Vitamind Consumer Packaged Goods Products

May 19, 2021

Vancouver, British Columbia--(Newsfile Corp. - May 19, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or...

Via Newsfile

Lobe Sciences to Present at the Benzinga Global Small Cap Conference

May 06, 2021

Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is...

Via Newsfile

Lobe Sciences Acquires Vitamind Line of Wellness Products

May 04, 2021

Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is...

Via Newsfile

Topics Intellectual Property

Lobe Sciences Announces Filing of PCT Application

April 29, 2021

Vancouver, British Columbia--(Newsfile Corp. - April 29, 2021) - Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE: LOBE) (OTC Pink:...

Via Newsfile

Topics Intellectual Property

Lobe Sciences Enters into LOI with Core One Labs to Form a Joint Venture for the Clinical Development of Biosynthetic Psilocybin

April 28, 2021

Vancouver, British Columbia--(Newsfile Corp. - April 28, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...

Via Newsfile

Lobe Sciences Enters into Joint Venture with Virtual Psychedelics Incorporated to Develop Multi-Sensory Pods for Clinical Psychedelic Use

April 27, 2021

Vancouver, British Columbia--(Newsfile Corp. - April 27, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or...

Via Newsfile

Topics Intellectual Property

Lobe Sciences Appoints Benjamin Kelmendi, MD from Yale University to Scientific Advisory Board

April 20, 2021

Vancouver, British Columbia--(Newsfile Corp. - April 20, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...

Via Newsfile

Lobe Sciences to Present at the Emerging Growth Conference on April 14, 2021

April 12, 2021

Vancouver, British Columbia--(Newsfile Corp. - April 12, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...

Via Newsfile

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.